Characterization of a new p53-mutated and hpv-negative human squamous-cell cervical carcinoma-derived cell-line.

Meiotic gene conversion: a signal of the basic recombination event in yeast. Cold Spring Harb Symp Quant Biol (1979) 7.46

Informational transfer in meiotic gene conversion. Proc Natl Acad Sci U S A (1969) 5.68

Biodegradation of chlorinated ethenes by a methane-utilizing mixed culture. Appl Environ Microbiol (1986) 4.93

Meiotic gene conversion in yeast tetrads and the theory of recombination. Genetics (1967) 4.78

MAR1-a Regulator of the HMa and HMalpha Loci in SACCHAROMYCES CEREVISIAE. Genetics (1979) 3.87

Tandem gene amplification mediates copper resistance in yeast. Proc Natl Acad Sci U S A (1982) 3.84

Meiotic gene conversion mutants in Saccharomyces cerevisiae. I. Isolation and characterization of pms1-1 and pms1-2. Genetics (1985) 3.71

A system selective for yeast mutants deficient in meiotic recombination. Mol Gen Genet (1971) 3.70

Conversion-associated recombination in yeast (hybrids-meiosis-tetrads-marker loci-models). Proc Natl Acad Sci U S A (1972) 3.57

Cloning and nucleotide sequence of DNA mismatch repair gene PMS1 from Saccharomyces cerevisiae: homology of PMS1 to procaryotic MutL and HexB. J Bacteriol (1989) 3.36

Heteroduplex DNA correction in Saccharomyces cerevisiae is mismatch specific and requires functional PMS genes. Mol Cell Biol (1989) 3.28

Primary structure and transcription of an amplified genetic locus: the CUP1 locus of yeast. Proc Natl Acad Sci U S A (1984) 3.28

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A (1992) 3.27

The Action of Homothallism Genes in Saccharomyces Diploids during Vegetative Growth and the Equivalence of hma and HMalpha Loci Functions. Genetics (1977) 3.15

Mismatch-specific post-meiotic segregation frequency in yeast suggests a heteroduplex recombination intermediate. Nature (1985) 2.98

Chemical basis for heterogeneity of ribosomal proteins. Proc Natl Acad Sci U S A (1968) 2.81

Synchronous mating in yeast. Proc Natl Acad Sci U S A (1973) 2.65

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci U S A (1995) 2.56

Yeast mutant defective in phosphatidylserine synthesis. J Biol Chem (1980) 2.47

The role of heteroduplex correction in gene conversion in Saccharomyces cerevisiae. Nature (1987) 2.38

Extraction and isolation of individual ribosomal proteins from Escherichia coli. J Bacteriol (1968) 2.27

Yeast mutants auxotrophic for choline or ethanolamine. J Bacteriol (1980) 2.24

Switching of a mating-type a mutant allele in budding yeast Saccharomyces cerevisiae. Genetics (1979) 2.23

Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res (1985) 2.06

Mitotic chromosome loss in a disomic haploid of Saccharomyces cerevisiae. Genetics (1975) 2.06

Mismatch repair-induced meiotic recombination requires the pms1 gene product. Genetics (1990) 1.91

Industrial yeasts display tandem gene iteration at the CUP1 region. Mol Cell Biol (1983) 1.84

Mutations affecting meiotic gene conversion in yeast. Mol Gen Genet (1974) 1.73

The CUP2 gene product regulates the expression of the CUP1 gene, coding for yeast metallothionein. EMBO J (1989) 1.63

Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol (2001) 1.60

Recombination in yeast. Annu Rev Genet (1971) 1.56

Complete nucleotide sequence of minicircle kinetoplast DNA from Trypanosoma equiperdum. Proc Natl Acad Sci U S A (1981) 1.56

Enhanced biodegradation of methoxychlor in soil under sequential environmental conditions. Appl Environ Microbiol (1982) 1.53

Saturated fatty acid mutants in yeast. Mol Gen Genet (1971) 1.51

Electron microscopy of the circular kinetoplastic DNA from Trypanosoma cruzi: occurrence of catenated forms. Proc Natl Acad Sci U S A (1969) 1.49

Recombinant repair of diverged DNAs: a study of homoeologous chromosomes and mammalian YACs in yeast. Mol Gen Genet (1992) 1.43

Association of chromosome loss with centromere-adjacent mitotic recombination in a yeast disomic haploid. Genetics (1977) 1.41

Activation of mating type genes by transposition in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1979) 1.41

A DNA sequence conferring high postmeiotic segregation frequency to heterozygous deletions in Saccharomyces cerevisiae is related to sequences associated with eucaryotic recombination hotspots. Mol Cell Biol (1988) 1.40

Chemical detection of microbial prey by bacterial predators. J Bacteriol (1971) 1.39

The CUP2 gene product, regulator of yeast metallothionein expression, is a copper-activated DNA-binding protein. Mol Cell Biol (1989) 1.38

Regulatory mutants at the his1 locus of yeast. Genetics (1979) 1.38

Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer (1989) 1.35

Preparation and properties of nuclear and satellite deoxyribonucleic acid of Trypanosoma cruzi. J Mol Biol (1967) 1.31

Mitotic recombination in yeast: isolation and characterization of mutants with enhanced spontaneous mitotic gene conversion rates. Genetics (1980) 1.24

Replicating, convalently closed, circular DNA from kinetoplasts of Trypanosoma cruzi. Proc Natl Acad Sci U S A (1972) 1.23

Genetic control of yeast mannan structure. Mapping the first gene concerned with mannan biosynthesis. J Biol Chem (1973) 1.22

High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene (1995) 1.18

ATP-independent type II topoisomerase from trypanosomes. Proc Natl Acad Sci U S A (1986) 1.16

Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res (1988) 1.16

Gene conversion, unequal crossing-over and mispairing at a non-tandem duplication during meiosis of Saccharomyces cerevisiae. Curr Genet (1987) 1.16

Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene (1990) 1.16

Unequal crossing-over and gene conversion at the amplified CUP1 locus of yeast. Mol Gen Genet (1990) 1.15

Meiotic recombination and sporulation in repair-deficient strains of yeast. Genetics (1985) 1.13

Microconversion between murine H-2 genes integrated into yeast. Nature (1990) 1.13

Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene (1988) 1.11

Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. Biochemistry (1986) 1.11

Biodegradation of [(sup14)C]Benzo[a]pyrene Added in Crude Oil to Uncontaminated Soil. Appl Environ Microbiol (1997) 1.10

Synchronous mating in yeasts. Methods Cell Biol (1975) 1.10

Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst (1989) 1.08

C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet (1987) 1.08

Expression of a human multidrug resistance gene in ovarian carcinomas. Cancer Res (1989) 1.06

Absence of kinetoplast DNA in a late antigenic variant of Trypanosoma equiperdum. Mol Biochem Parasitol (1980) 1.06

Meiotic gene conversion mediates gene amplification in yeast. Cold Spring Harb Symp Quant Biol (1984) 1.05

High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene (1996) 1.04

The detection of mitotic and meiotic aneuploidy in yeast using a gene dosage selection system. Mol Gen Genet (1988) 1.04

Antibodies against cytochromes c from vertebrates. J Biol Chem (1966) 1.02

Reversion at the HiS1 locus of yeast. Genetics (1978) 1.02

Abnormal circular DNA molecules induced by ethidium bromide in the kinetoplast of Trypanosoma cruzi. Proc Natl Acad Sci U S A (1969) 1.02

DIS1: a yeast gene required for proper meiotic chromosome disjunction. Genetics (1988) 1.01

The p53 and mdm-2 genes in human testicular germ-cell tumors. Mol Carcinog (1995) 1.01

Familial clustering of breast cancer: possible interaction between DNA repair proficiency and radiation exposure in the development of breast cancer. Int J Cancer (1995) 1.01

[Fractionation and characterization of desoxyribonucleic acid (DNA) of trypanosomes (Trypanosoma equiperdum)]. C R Acad Sci Hebd Seances Acad Sci D (1966) 1.00

c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients. Int J Cancer (2001) 0.98

Gene conversion of the mating-type locus in Saccharomyces cerevisiae. Genetics (1979) 0.97

Occurrence of a kinetoplast DNA-protein complex in Trypanosoma cruzi. Biochem Biophys Res Commun (1981) 0.97

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers. Oncogene (2000) 0.96

Fruit pit obstruction leading to the diagnosis of Crohn's disease. Am J Surg (2001) 0.96

Nuclear and mitochondrial deoxyribonucleic acid replication during mitosis in Saccharomyces cerevisiae. J Bacteriol (1975) 0.95

Multicopy CUP1 plasmids enhance cadmium and copper resistance levels in yeast. Mol Gen Genet (1991) 0.95

[Induction of a "dyskinetoplast" by ethidium bromide in Trypanosoma cruzi cultivated in vitro]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.94

Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res (1991) 0.93

Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res (1994) 0.93

Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer (1990) 0.93

Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet (2005) 0.92

c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients. Int J Cancer (1999) 0.92

Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts. Cancer Gene Ther (2000) 0.91

[Study of kinetoplast DNA of Trypansoma cruzi using restriction endonucleases]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.90

In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei. Am J Pathol (2001) 0.90

c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis. Int J Cancer (1995) 0.90

Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. Br J Cancer (2002) 0.89

Ultrastructural alterations of Trypanosoma cruzi kinetoplast induced by the interaction of a trypanocidal drug (hydroxystilbamidine) with the kinetoplast DNA. J Ultrastruct Res (1971) 0.89